Oral antivirals ritonavir-nirmatrelvir and molnupiravir are highly effective in patients with multiple myeloma and COVID-19;a singlecenter, prospective study

Spiliopoulou, Vassiliki, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Gavriatopoulou, Maria, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Dimopoulos, Meletios A.; Terpos, Evangelos

Spiliopoulou, Vassiliki, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Gavriatopoulou, Maria, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Dimopoulos, Meletios A.; Terpos, Evangelos.

Clinical lymphoma, myeloma & leukemia ; 22(8):S123-S124, 2022.

Article in English | EuropePMC | ID: covidwho-2012618

Search on Google

XML

Collection: Databases of international organizations Database: EuropePMC Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: English Journal: Clinical lymphoma, myeloma & leukemia Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML